Work

Biosimilars for anti-VEGF treatment of macular diseases: country and region reports

Year: 2025

Type: article

Abstract: Biosimilars for anti-VEGF treatment of macular diseases: country and region reportsBiosimilars can improve patients' access to anti-VEGF treatment for macular diseases, but only if they are approved for local use and are readily available.Anti-VEGF injection.

Source: Community Eye Health Journal

DOI: 10.56920/cehj.835

Authors: Miriam Cano, Mangala Dhanapala, Mengtian Kang, Mapa Prabhath Piyasena, Rajiv Raman, David Yorston

Institutions: Universidad Católica Nuestra Señora de la Asunción, Beijing Tongren Hospital, Anglia Ruskin University, Sankara Nethralaya, Indian Institute of Technology Madras, Gartnavel General Hospital

Language: English

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4408957031

FWCI: 0.61

Cites:

Cited by: 2

Related to: 10